RxDoctor Payments Data

Erel Joffe

Hematology & Oncology · New York, NYNPI 1831619063

Payments from drug & device makers

$1,456,743in general payments, 2019–2025

Across 47 payments — averaging $30,995 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Morphosys AG$735K
  • Beigene, Ltd.$339K
  • Amgen$228K
  • Janssen Research & Development, LLC$128K
  • Beigene AUS Pty Ltd$23K
  • AstraZeneca$3K

What the payments were for

  • Consulting fees$2,800100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Morphosys AG6$734,903
Beigene, Ltd.6$339,212
Amgen3$228,344
Janssen Research & Development, LLC27$128,395
Beigene AUS Pty Ltd4$23,089
AstraZeneca1$2,800

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,456,743 in reported general payments places this provider in the 90th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York

Other hematology & oncology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →